Description
Buy 2 Get 1 Free Blend CJC 1295 NO DAC 5mg with GHRP-2 5mg :
| Unit Size | 10 mg/vial |
| Unit Quantity | 1 vial |
| Purity (Mass Spectrometry and UV) | 99.49% Nominal Target: 5 mg CJC 1295 NO DAC + 5 mg GHRP-2 |
| Sequence (CJC 1295 NO DAC) | H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu- Ser-Ala-Arg-Lys-Leu–Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Sequence (GHRP 2) | H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 |
| Molecular Formula (CJC 1295 NO DAC) |
C152H252N44O42 |
| Molecular Formula (GHRP 2) | C45H55N9O6 |
| Appearance | Lyophilized White Powder |
| Source | Chemical Synthesis |
| Storage | Lyophilized Blend CJC 1295 NO DAC with GHRP-2 is stable at roomTemperature for 90 days, however it is best to store in a freezer below – 8c for any extended period of time. |
| Terms | The products we offer are intended for laboratory research use only. Please familiarize yourself with our terms of service prior to ordering. |
Blend CJC-1295 NO-DAC 5mg with GHRP-2 5mg
View Research Overview & References
CJC-1295 NO-DAC with GHRP-2 combines a synthetic analog of growth hormone-releasing hormone (GHRH) with growth hormone-releasing peptide-2 (GHRP-2). CJC-1295 is composed of 30 amino acids and has a molecular weight of 3647.16 g/mol, derived from sermorelin (GHRH 1-29), and formulated without a drug affinity complex (DAC), resulting in a shorter half-life compared to CJC-1295 with DAC.1 This formulation is studied for short-term research on growth hormone-related signaling pathways.
Animal Model Research
In an animal model study using GHRH-deficient mice, research examined CJC-1295’s effects on growth hormone (GH) and insulin-like growth factor-1 (IGF-1) related signaling.2 GHRP-2 is studied for its interaction with the growth hormone secretagogue receptor, relevant to research on GH-related signaling pathways.
Combined Research Applications
Laboratory research has examined this peptide combination for its effects on GH and IGF-1 signaling pathways, contributing to basic research on metabolic and muscle-related cell signaling.
Important Notice
CJC-1295 NO-DAC with GHRP-2 is intended strictly for in vitro and in vivo (animal) laboratory research only and is not for human or animal consumption, diagnostic use, or therapeutic use. Researchers utilize this product to investigate the biochemical mechanisms of growth hormone pathways under controlled experimental conditions, and it has not been evaluated for safety or efficacy in humans or animals.
Product Information
CJC-1295 NO-DAC with GHRP-2 is supplied as a white lyophilized powder at a concentration of 10 mg per vial (5 mg x 2).
References
1. Jette L, Leger R, Thibaudeau K, et al. Human Growth Hormone-Releasing Factor (hGRH) 1-29 – Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog. Endocrinology. 2005 Jul;146(7):3052-3058.
2. Alba M, Fintini D, Sagazio A, et al. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1290-4.
